自願公告 收購高脈健康股權 本公告由江西一脈陽光集團股份有限公司（「本公司」，連同其附屬公司統稱為「本 集團」）董事（「董事」）會（「董事會」）自願作出，以通知本公司股東（「股東」）及本 公司的潛在投資者有關本集團的最新業務發展。 董事會欣然宣佈，於2025年6月22日，本公司全資附屬公司江西贛江新區一脈陽 光健康管理有限公司（「一脈陽光健康管理」）（作為買方）、廣東高尚健康科技集團 有限公司（「賣方I」）、廈門高尚醫學影像診斷中心有限公司（「賣方II」）及合肥高 尚醫學影像診斷中心有限公司（「賣方III」）（作為賣方，統稱為「賣方」）與廣州高 脈健康科技有限公司（「高脈健康」）訂立股權轉讓協議（「股權轉讓協議」），據此， 一脈陽光健康管理將分別向賣方I、賣方II及賣方III收購高脈健康的30.0%、20.0% 及20.0%股權（「收購事項」），總代價為人民幣54,000,000元。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部分內容所產生或因依 賴該等內容而引致的任何損失承擔任何責任。 Jiangxi R ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部分內容所產生或因依 賴該等內容而引致的任何損失承擔任何責任。 Jiangxi Rimag Group Co., Ltd. 江西一脈陽光集團股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：2522） 自願公告 收購眾雅診斷股權 本公告由江西一脈陽光集團股份有限公司（「本公司」，連同其附屬公司統稱為「本 集團」）董事（「董事」）會（「董事會」）自願作出，以通知本公司股東（「股東」）及本 公司的潛在投資者有關本集團的最新業務發展。 董事會欣然宣佈，於2025年6月9日（交易時段後），本公司擁有55.0%權益的附屬 公司湖南一脈陽光醫學影像診斷中心有限公司（「湖南一脈」）（作為買方）、長沙市 眾雅健康產業集團有限公司（作為賣方，「賣方」）與長沙眾雅醫學影像診斷有限公 司（「眾雅診斷」）訂立股權轉讓協議（「股權轉讓協議」），據此，湖南一脈將向賣方 收購眾雅診斷的100.0%股權（「收購事項」），總代價為人民幣29,500,000元。 於本公告日期，湖南 ...

Summary of Arden Health Partners Conference Call Company Overview - **Company**: Arden Health Partners - **Industry**: Healthcare Facilities and Managed Care Key Points Volume Trends - Q1 volumes were at the higher end of full-year guidance, indicating strong performance despite calendar headwinds such as flu season [2][3] - The company operates in eight mid-sized urban markets that are growing approximately three times faster than the U.S. average, contributing to volume growth [4] - Strategies such as service line development and rationalization are in place to sustain and accelerate volume growth [5] Outpatient vs. Inpatient Trends - Outpatient volumes were weaker compared to inpatient volumes, attributed to calendar impacts and economic uncertainty [6] - The company is focusing on expanding outpatient services, including urgent care and ambulatory surgical centers (ASCs), to capture more patient volume [8][10] - The total addressable market consists of approximately 5.6 million people in the company's markets, with significant opportunities for outpatient growth [9] Joint Venture Model - Arden's joint venture model is unique in the publicly traded hospital sector, allowing for operational efficiencies and improved service delivery [21][22] - Partnerships with academic institutions, such as the University of Texas, have led to improved services and financial performance [24][27] - The model fosters a "flywheel effect," enhancing recruitment and training of medical professionals [27] Labor and Cost Management - The workforce has stabilized, with a reduction in contract labor usage from COVID-19 peaks [46][47] - The company is focused on improving nurse retention and reducing turnover, which has positively impacted labor costs [47] - Professional fees, which account for about 7% of revenues, are a growing cost pressure, but the company is negotiating with payers to manage these costs [51][52] Regulatory Environment - The company is optimistic about the durability of directed payment programs (DPPs) and believes initial proposals will not negatively impact existing programs [30][31] - There are ongoing discussions in Congress regarding physician payment reforms, with hopes for sustainable solutions [55][57] Growth Strategy - Arden is exploring acquisition opportunities to expand its market presence, particularly in struggling hospitals [66][67] - The company is managing cash flow tightly while balancing slow payments from payers and capital expenditures [68] Financial Outlook - The company expects continued margin improvement through operational efficiencies and outpatient growth, with a long-term volume growth target of 2-3% [8][40] - The focus remains on building a scalable and robust operating model to enhance profitability [41][42] Additional Insights - The company emphasizes the importance of physician relationships in driving patient volume and ensuring facility-based care referrals [28][29] - There is a noted increase in denial rates, but the majority of claims are being paid, indicating a focus on improving revenue cycle management [62][63] This summary encapsulates the key insights and strategic directions discussed during the conference call, highlighting Arden Health Partners' operational performance, market strategies, and financial outlook.